z-logo
open-access-imgOpen Access
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Author(s) -
Mahmoud Elsawy,
Julio C. Chávez,
Irit Avivi,
Jean-François Larouche,
Luciano Wannesson,
Kate Cwynarski,
Keren Osman,
Kelly Davison,
Jakob Rudzki,
Saurabh Dahiya,
Kathleen A. Dorritie,
Samantha Jaglowski,
John Radford,
Franck Morschhauser,
David Cunningham,
Alejandro Martı́n,
Dimitrios Tzachanis,
Matthew L. Ulrickson,
Reem Karmali,
Natasha Kekre,
Catherine Thiéblemont,
Gunilla Enblad,
Peter Dreger,
Ram Malladi,
Namita Joshi,
WeiJhih Wang,
Caitlyn T. Solem,
Julia Thornton Snider,
Paul Cheng,
Christina To,
Marie José Kersten
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022015478
Subject(s) - medicine , quality of life (healthcare) , confidence interval , visual analogue scale , phases of clinical research , oncology , clinical trial , physical therapy , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom